EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Non-dilated left ventricular cardiomyopathy in patients with chronic Chagas disease and heart failure with reduced left ventricular ejection fraction

Reinaldo B Bestetti iD, Augusto Cardinalli-Neto, Ana Paula Otaviano iD, Mauricio N Machado, Paulo R Pavarino, Marcelo A Nakazone iD

ESC Heart Failure · 2026

DOI: 10.1093/eschf/xvag020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ESC Heart Failure, 2026. Verfasst von Reinaldo B Bestetti und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Ribeirão Preto, Ribeirão Preto city 14096-900, Brazil. Hauptthemen laut MEDLINE: Stroke Volume, Chagas Cardiomyopathy, Heart Failure, Ventricular Function, Left. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Ribeirão Preto.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The aim of this investigation was to establish the clinical characteristics and outcomes of patients with non-dilated left ventricular cardiomyopathy (NDLVC) secondary to chronic Chagas disease (CChD).

Methods

All patients with CChD followed at our institution from January 2000 to January 2010 were included. Patients with a left ventricular ejection fraction (LVEF) <50%, a left ventricular diastolic diameter (LVDD) <55 mm, and segmental wall motion abnormalities (SWMA) on echocardiography were diagnosed with NDLVC secondary to CChD. The remaining patients had dilated cardiomyopathy (DCM) secondary to CChD.

Results

Of the 215 patients, 21 (10%) had NDLVC. In this group, the mean age was 62 ± 9 years, 12 (57%) were male, the median daily dose of metoprolol was 100 (62, 5, 125) mg, the LVDD was 51 ± 29 mm, and the LVEF was 39 ± 6.4%. SWMA were found in 12 (57%) patients. Mean follow-up 50.8 ± 3.8 months, during which 9 (43%) patients died. In a Cox regression model, Beta-blocker therapy was the only independent predictor of all-cause mortality for patients with NDLVC (hazard ratio = 0.16, 95% CI 0.04-0.68; P = .01) Over a 60-month follow-up, Kaplan-Meier survival estimates at 12, 24, 36, 48, and 60 months, were 71%, 71%, 59%, 59%, and 59%, respectively, in patients with NDLVC, and 77%, 61%, 49%, 38%, and 30%, respectively, in those with DCM due to CChD (P = .04).

Conclusions

Non-dilated left ventricular cardiomyopathy affects one in 10 patients with CHF due to CChD, and the 5-year survival rate is 59%.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stroke VolumeChagas CardiomyopathyHeart FailureVentricular Function, LeftVentricular Dysfunction, LeftHeart VentriclesHumansMaleFemaleMiddle AgedEchocardiographyRetrospective StudiesChronic DiseaseFollow-Up StudiesSurvival Rate

Stichwörter der Autor:innen

Chagas cardiomyopathyChagas diseaseHeart failureInherited cardiomyopathyNon-dilated left ventricular cardiomyopathy

Autor:innen und Institutionen

  • Department of Medicine, University of Ribeirão Preto, Ribeirão Preto city 14096-900, Brazil.
  • Division of Postgraduation, São José do Rio Preto Medical School, São José do Rio Preto city, Brazil.
  • Fundação Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto city, Brazil.
  • Department of Cardiology and Cardiovascular Surgery, São José do Rio Preto Medical School, São José do Rio Preto city, Brazil.

ORCID-Profile: Reinaldo B Bestetti, Ana Paula Otaviano, Marcelo A Nakazone

Förderung

  • University of Ribeirão Preto

Zitieren

APA

Bestetti, R. B., Cardinalli-Neto, A., Otaviano, A. P., Machado, M. N., Pavarino, P. R., & Nakazone, M. A. (2026). Non-dilated left ventricular cardiomyopathy in patients with chronic Chagas disease and heart failure with reduced left ventricular ejection fraction. ESC Heart Failure. https://doi.org/10.1093/eschf/xvag020

Vancouver

Bestetti RB, Cardinalli-Neto A, Otaviano AP, Machado MN, Pavarino PR, Nakazone MA. Non-dilated left ventricular cardiomyopathy in patients with chronic Chagas disease and heart failure with reduced left ventricular ejection fraction. ESC Heart Failure. 2026. doi:10.1093/eschf/xvag020

BibTeX
@article{Bestetti2026,
  author = {Bestetti, Reinaldo B and Cardinalli-Neto, Augusto and Otaviano, Ana Paula and Machado, Mauricio N and Pavarino, Paulo R and Nakazone, Marcelo A},
  title = {Non-dilated left ventricular cardiomyopathy in patients with chronic Chagas disease and heart failure with reduced left ventricular ejection fraction},
  journal = {ESC Heart Failure},
  year = {2026},
  doi = {10.1093/eschf/xvag020}
}
Kostenlos starten →